Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.930
+0.030 (1.58%)
Jun 6, 2025, 4:00 PM - Market closed

APUS Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.2500.410.010.17
Cash & Short-Term Investments
0.2500.410.010.17
Cash Growth
69.86%-99.16%6551.77%-96.40%-
Prepaid Expenses
0.010.010.01-0
Total Current Assets
0.260.010.420.010.17
Total Assets
0.260.010.420.010.17
Accounts Payable
----0.01
Accrued Expenses
1.050.70.120.04-
Short-Term Debt
0.340.33-0.28-
Current Income Taxes Payable
---0-
Total Current Liabilities
1.771.020.120.320.01
Long-Term Debt
0.250.350.270.40.4
Total Liabilities
2.021.370.390.720.41
Common Stock
0.080.080.080.10.1
Additional Paid-In Capital
2.952.952.951.411.22
Retained Earnings
-4.79-4.39-3-2.22-1.56
Shareholders' Equity
-1.76-1.360.03-0.71-0.24
Total Liabilities & Equity
0.260.010.420.010.17
Total Debt
0.970.670.270.680.4
Net Cash (Debt)
-0.72-0.670.14-0.68-0.23
Net Cash Per Share
-0.09-0.080.03-0.18-0.06
Filing Date Shares Outstanding
11.588.197.95.773.85
Total Common Shares Outstanding
7.97.97.95.773.85
Working Capital
-1.51-1.010.3-0.310.16
Book Value Per Share
-0.22-0.170.00-0.12-0.06
Tangible Book Value
-1.76-1.360.03-0.71-0.24
Tangible Book Value Per Share
-0.22-0.170.00-0.12-0.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q